
About ACBM
The Association for Cognitive Bias Modification (ACBM) is committed to improving CBM research and application in a manner that reflects scientific rigour, clinical integrity, and dissemination of evidence-based assessment and therapeutics.
Mission
- Refining assessments of cognitive biases associated with dysfunctional psychological processes.
- Optimizing training procedures to modify cognitive biases.
- Leveraging the understanding of mechanisms to maximise their therapeutic benefits.
Consistent with this mission, the Association engages in the following three key activities:
- Developing guidelines and software resources to promote the adoption of reliable and valid approaches for assessing cognitive biases.
- Designing and evaluating methods of delivering cognitive bias modification procedures that maximise their capacity to engage their targets.
- Translating the resulting scientific advances into empirically-validated CBM interventions that are accessible, scalable, and sustainable within the clinical setting.
History of ACBM
A description of ACBM’s founding process, preliminary meetings in London, Washington DC, Amsterdam, and Berlin will appear soon.
Leadership

Eni Becker, PhD
President
Board Term 2023-2026
Professor Eni S. Becker is the Chair of Clinical Psychology at Radboud University, The Netherlands, focusing on cognitive processes and their role in psychopathology, with a specific interest in anxiety and affective disorders. Her passion for bridging the gap between fundamental and applied research in clinical psychology is evident in her work. She firmly believes that CBM is an essential tool in achieving this goal. Eni brings a wealth of experience, enthusiasm, and a strong team spirit that fosters critical discourse and interdisciplinary collaboration. She is committed to leveraging her expertise to drive ACBM’s mission to promote and advance the field of cognitive bias modification towards better research, ultimately benefiting patients.

Yair Bar-Haim, PhD
Immediate Past President
Board Term 2023-2026
Professor Bar-Haim is based at Tel Aviv University’s, School of Psychological Science and Sagol School of Neuroscience. He is the Director of the Adler Center for Development and Psychopathology and the Israeli National Center for Traumatic Stress and Resilience (NC-TSR). Professor Bar-Haim’s research focuses on cognitive, neural, and genetic mechanisms underlying stress-related disorders in children, adolescents, and adults. The primary effort of his research is translation of basic science into effective evidence-supported CBM therapies. Professor Bar-Haim’s group developed and tested various mechanized treatments for anxiety and stress-related disorders as well as largescale CBM prevention programs for combat-related PTSD.
Board

Jennifer Lau, PhD
President Elect
Board Term 2025-2026

Julian Basanovic, PhD
Secretary
Board Term 2025-2028

Jeremy Pettit, PhD
Treasurer
Board Term 2025-2028

Amit Lazarov, PhD
Science Director
Board Term 2023-2026

Mike Rinck, PhD
Membership Secretary
Board Term 2025-2028

Julie Ji, PhD
Public Engagement Director
Board Term 2023-2026

Marcella Woud, PhD
General Director
Board Term 2023-2026

Victoria Manning, PhD
General Director
Board Term 2023-2026

Melissa Brotman, PhD
General Director
Board Term 2023-2026

Daniel S. Pine, MD
Co-opted General Director
Board Term 2023-2026

Colin MacLeod, PhD
Co-opted General Director
Board Term 2023-2026

Charlotte Wittekind, PhD
Co-opted General Director
Board Term 2023-2026

Nilly Mor, PhD
Co-opted General Director
Board Term 2025-2026
Advisory Roles

Nader Amir, PhD

Reinout Wiers, PhD

Elske Salemink, PhD

Ali Khatibi, PhD